Study: Arthritis drug cuts death risk in hospitalized COVID-19 patients with pneumonia
Treatment with a rheumatoid arthritis drug reduced the risk for death from pneumonia caused by COVID-19 among hospitalized patients by nearly 40%, a study published Monday by JAMA Internal Medicine found.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Arthritis | COVID-19 | Health | Internal Medicine | Pneumonia | Rheumatoid Arthritis | Rheumatology | Study